Skip to main content

What the FDA labels say about taking them together

Dantrolene and warfarin

Dantrolene's FDA label (Dantrium) of March 10, 2026 names warfarin in its drug interactions section; the warfarin label PlainMeds reads does not name dantrolene. The dantrolene label: “Binding to plasma proteins is reduced by warfarin and clofibrate and increased by tolbutamide.”

Check it at the source: the dantrolene FDA label on DailyMed (effective August 21, 2026, Par Health USA, LLC); the warfarin FDA label on DailyMed (effective May 29, 2026, Amneal Pharmaceuticals LLC).

What does the dantrolene label say about warfarin?

Dantrium label (Par Health USA, LLC, March 10, 2026), drug interactions

Binding to plasma proteins is reduced by warfarin and clofibrate and increased by tolbutamide.

Source: FDA drug label (Dantrium, NDA018264), Par Health USA, LLC, effective March 10, 2026 (SPL set 4df35098-8702-46be-ac67-30cfdf1aa570), via openFDA

Source: FDA drug label (dantrolene sodium), Par Health USA, LLC, effective August 21, 2026 (SPL set 11689f56-15e0-4350-b53f-ae96e5994fea), via openFDA; the full label on DailyMed

What does the warfarin label say about dantrolene?

Warfarin's label (effective May 29, 2026) does not name dantrolene in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Warfarin Sodium), Amneal Pharmaceuticals LLC, effective May 29, 2026 (SPL set 558b7a0d-5490-4c1b-802e-3ab3f1efe760), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

10Dantrolene generic labelers
19Warfarin generic labelers
DantroleneWarfarin
Labeled forMuscle spasms and spasticityBlood clots (DVT and PE), Atrial fibrillation
Boxed warningYesYes
Pharmacy cost (NADAC)$0.409 per capsule 25 mg capsule$0.093 per tablet 2 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?